354 related articles for article (PubMed ID: 25376633)
1. Gold-nanoparticle-based multifunctional amyloid-β inhibitor against Alzheimer's disease.
Gao N; Sun H; Dong K; Ren J; Qu X
Chemistry; 2015 Jan; 21(2):829-35. PubMed ID: 25376633
[TBL] [Abstract][Full Text] [Related]
2. Gold nanoparticle-capped mesoporous silica-based H
Yang L; Yin T; Liu Y; Sun J; Zhou Y; Liu J
Acta Biomater; 2016 Dec; 46():177-190. PubMed ID: 27619837
[TBL] [Abstract][Full Text] [Related]
3. Transition-metal-substituted polyoxometalate derivatives as functional anti-amyloid agents for Alzheimer's disease.
Gao N; Sun H; Dong K; Ren J; Duan T; Xu C; Qu X
Nat Commun; 2014 Mar; 5():3422. PubMed ID: 24595206
[TBL] [Abstract][Full Text] [Related]
4. Negatively charged gold nanoparticles inhibit Alzheimer's amyloid-β fibrillization, induce fibril dissociation, and mitigate neurotoxicity.
Liao YH; Chang YJ; Yoshiike Y; Chang YC; Chen YR
Small; 2012 Dec; 8(23):3631-9. PubMed ID: 22915547
[TBL] [Abstract][Full Text] [Related]
5. Label-free detection of ApoE4-mediated β-amyloid aggregation on single nanoparticle uncovering Alzheimer's disease.
Kang MK; Lee J; Nguyen AH; Sim SJ
Biosens Bioelectron; 2015 Oct; 72():197-204. PubMed ID: 25982728
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Mechanism of Inhibition of Au Nanoparticles on the Aggregation of Amyloid-β(16-22) Peptides at the Atom Level by All-Atom Molecular Dynamics.
Song M; Sun Y; Luo Y; Zhu Y; Liu Y; Li H
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29925792
[TBL] [Abstract][Full Text] [Related]
7. Current Strategies for Modulating Aβ Aggregation with Multifunctional Agents.
Du Z; Li M; Ren J; Qu X
Acc Chem Res; 2021 May; 54(9):2172-2184. PubMed ID: 33881820
[TBL] [Abstract][Full Text] [Related]
8. Amyloid-β aggregation with gold nanoparticles on brain lipid bilayer.
Lee H; Kim Y; Park A; Nam JM
Small; 2014 May; 10(9):1779-89. PubMed ID: 24664514
[TBL] [Abstract][Full Text] [Related]
9. Graphene quantum dots for the inhibition of β amyloid aggregation.
Liu Y; Xu LP; Dai W; Dong H; Wen Y; Zhang X
Nanoscale; 2015 Dec; 7(45):19060-5. PubMed ID: 26515666
[TBL] [Abstract][Full Text] [Related]
10. Self-assembled peptide-polyoxometalate hybrid nanospheres: two in one enhances targeted inhibition of amyloid β-peptide aggregation associated with Alzheimer's disease.
Li M; Xu C; Wu L; Ren J; Wang E; Qu X
Small; 2013 Oct; 9(20):3455-61. PubMed ID: 23650245
[TBL] [Abstract][Full Text] [Related]
11. Peptide multifunctionalized gold nanorods decrease toxicity of β-amyloid peptide in a Caenorhabditis elegans model of Alzheimer's disease.
Morales-Zavala F; Arriagada H; Hassan N; Velasco C; Riveros A; Álvarez AR; Minniti AN; Rojas-Silva X; Muñoz LL; Vasquez R; Rodriguez K; Sanchez-Navarro M; Giralt E; Araya E; Aldunate R; Kogan MJ
Nanomedicine; 2017 Oct; 13(7):2341-2350. PubMed ID: 28673851
[TBL] [Abstract][Full Text] [Related]
12. Mo polyoxometalate nanoclusters capable of inhibiting the aggregation of Aβ-peptide associated with Alzheimer's disease.
Chen Q; Yang L; Zheng C; Zheng W; Zhang J; Zhou Y; Liu J
Nanoscale; 2014 Jun; 6(12):6886-97. PubMed ID: 24834443
[TBL] [Abstract][Full Text] [Related]
13. The size-effect of gold nanoparticles and nanoclusters in the inhibition of amyloid-β fibrillation.
Gao G; Zhang M; Gong D; Chen R; Hu X; Sun T
Nanoscale; 2017 Mar; 9(12):4107-4113. PubMed ID: 28276561
[TBL] [Abstract][Full Text] [Related]
14. Identification of a Novel Multifunctional Ligand for Simultaneous Inhibition of Amyloid-Beta (Aβ
Asadbegi M; Shamloo A
ACS Chem Neurosci; 2019 Nov; 10(11):4619-4632. PubMed ID: 31566950
[TBL] [Abstract][Full Text] [Related]
15. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
Savelieff MG; DeToma AS; Derrick JS; Lim MH
Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
[TBL] [Abstract][Full Text] [Related]
16. β-sheet interfering molecules acting against β-amyloid aggregation and fibrillogenesis.
Francioso A; Punzi P; Boffi A; Lori C; Martire S; Giordano C; D'Erme M; Mosca L
Bioorg Med Chem; 2015 Apr; 23(8):1671-83. PubMed ID: 25769517
[TBL] [Abstract][Full Text] [Related]
17. Novel β-amyloid aggregation inhibitors possessing a turn mimic.
Hamada Y; Miyamoto N; Kiso Y
Bioorg Med Chem Lett; 2015 Apr; 25(7):1572-6. PubMed ID: 25736996
[TBL] [Abstract][Full Text] [Related]
18. NABi, a novel β-sheet breaker, inhibits Aβ aggregation and neuronal toxicity: Therapeutic implications for Alzheimer's disease.
Jang JY; Rhim H; Kang S
Biochim Biophys Acta Gen Subj; 2018 Jan; 1862(1):71-80. PubMed ID: 29107146
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Lan JS; Xie SS; Li SY; Pan LF; Wang XB; Kong LY
Bioorg Med Chem; 2014 Nov; 22(21):6089-104. PubMed ID: 25282654
[TBL] [Abstract][Full Text] [Related]
20. Design of a Molecular Hybrid of Dual Peptide Inhibitors Coupled on AuNPs for Enhanced Inhibition of Amyloid β-Protein Aggregation and Cytotoxicity.
Xiong N; Zhao Y; Dong X; Zheng J; Sun Y
Small; 2017 Apr; 13(13):. PubMed ID: 28112856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
